• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- ​​​​​​​Sierra Leone battles intense mpox activity as Ethiopia reports first death

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/mpox/sie...se-mpox-activity-ethiopia-reports-first-death

Sierra Leone battles intense mpox activity as Ethiopia reports first death



Lisa Schnirring


Today at 12:54 p.m.

Mpox
Mpox activity in Africa continues at a brisk pace, with concerns about rising cases in newly affected countries such as Sierra Leone and the outbreak turning deadly in Ethiopia, a top official from the Africa Centres for Disease Control and Prevention (Africa CDC) said yesterday at the group’s weekly briefing.

Ngashi Ngongo, MD, PhD, MPH, who leads Africa CDC's mpox incident management team, said that, as of May, the number of lab-confirmed cases (17,845) has nearly reached the total reported for all of 2024.

Weighing continued emergency declarations


Different countries are at different stages of the outbreak, a complex situation complicated by the involvement of different clades and transmission patterns. Ngongo said the outbreak in Sierra Leone is still very concerning and is driving illnesses, with the country making up 53% of cases in the most recent reporting week.

High population density and tourism are major contributors to virus spread, and test positivity is as high as 100% in seven of the country’s districts, a sign that surveillance is still in a passive mode, Ngongo said.

Though 94% of Africa's cases last week were in four of the hardest-hit countries, he said upward trends continue in some of the newly affected countries, such as Togo and Ethiopia.

Africa CDC's mpox emergency committee met last week to assess if the situation still warrants a public health emergency of continental concern, and the World Health Organization mpox emergency committee met yesterday for the fourth time to assess the African developments.

In vaccine developments, the Democratic Republic of the Congo last week received 100,000 Jynneos doses from France and 1.5 million doses of the LC16 vaccine from Japan. Also, Sierra Leone is slated to receive 20,000 doses from the United Arab Emirates today.

Ethiopia reports first mpox death


Ethiopia confirmed its first mpox cases in late May, with 3 infections reported, and last week the total rose sharply, to 40 cases, 17 of them confirmed. New cases reflect northward spread beyond the initial illnesses, which were detected on the border with Kenya.

Ngongo said the patient who died is an infant, and though the clade hasn’t been confirmed yet, it's possible that it involves 1b, which has been circulating in neighboring Kenya.​
 
Back
Top Bottom